Greenwich LifeSciences, Inc. (GLSI)

Greenwich LifeSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10.51	6.18	4.09	6.99	13.47	27.2
Cash & Short-Term Investments	10.51	6.18	4.09	6.99	13.47	27.2
Cash Growth	282.02%	50.98%	-41.45%	-48.10%	-50.49%	-5.08%
Total Current Assets	10.51	6.18	4.09	6.99	13.47	27.2
Other Intangible Assets	-	-	0	0.01	0.01	0.01
Total Assets	10.51	6.18	4.09	6.99	13.48	27.22
Accounts Payable	4.51	4.87	2.8	0.26	0.22	0.22
Other Current Liabilities	0.73	0.95	0.38	0.04	0.04	0.16
Total Current Liabilities	5.24	5.82	3.19	0.29	0.26	0.39
Total Liabilities	5.24	5.82	3.19	0.29	0.26	0.39
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	98.05	87.48	68.67	57.05	54.67	60.47
Retained Earnings	-92.79	-87.14	-67.78	-50.36	-41.47	-33.65
Shareholders' Equity	5.27	0.35	0.91	6.7	13.21	26.83
Total Liabilities & Equity	10.51	6.18	4.09	6.99	13.48	27.22
Net Cash (Debt)	10.51	6.18	4.09	6.99	13.47	27.2
Net Cash Growth	70.05%	50.98%	-41.45%	-48.10%	-50.49%	-5.08%
Net Cash Per Share	0.78	0.46	0.31	0.54	1.04	2.10
Book Value	5.27	0.35	0.91	6.7	13.21	26.83
Book Value Per Share	0.39	0.03	0.07	0.52	1.02	2.07
Tangible Book Value	5.27	0.35	0.91	6.7	13.21	26.82
Tangible Book Value Per Share	0.39	0.03	0.07	0.52	1.02	2.07

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jun 3, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 5, 2026

Data Sources Report a data error